Preoperative management using inhalation therapy for pulmonary complications in lung cancer patients with chronic obstructive pulmonary disease
Authors:
Open Access
- 9 March 2017
- journal article
- research article
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 65 (7) , 388-391
Abstract
Objective This study aimed to investigate whether perioperative inhalations of long-acting beta-agonists (LABAs) or long-acting muscarinic antagonists (LAMAs) might decrease the incidence of postoperative complications in lung cancer patients with chronic obstructive pulmonary disease (COPD). Methods We retrospectively analyzed 108 patients with COPD who underwent pulmonary resections for primary lung cancer at our hospital between January 2013 and January 2016 to determine the association between the incidence of postoperative complications (e.g., prolonged air leakage and pneumonia) and the use of LABAs or LAMAs. Results Thirty patients with COPD experienced postoperative complications (27.8%): Fourteen patients had prolonged air leakages (more than 7 days), ten patients developed pneumonia. The frequency of these postoperative pulmonary complications was significantly higher among the patients with COPD (24/108 cases, 22.2%), compared with the frequency among non-COPD patients (15/224 cases, 6.7%). Inhaled bronchodilators, such as LAMA or LABA, were prescribed for 34 of the 108 patients with COPD; the remaining 74 patients were not treated with bronchodilators. Pulmonary complications were significant lower among the LAMA or LABA users (3/34 cases, 8.8%) than among the untreated COPD patients (21/74 cases, 28.4%). Conclusion For lung cancer patients with COPD, preoperative management using LABA or LAMA bronchodilators and smoking cessation can reduce the frequency of postoperative pulmonary complications after surgical lung resection. LAMA or LABA inhalation might be useful for not only perioperative care, but also for the long-term survival of COPD patients after surgery.Keywords
Funding Information
- Scientific Research (C) from Japan Society for the Promotion of Science (JSPS) (KAKENHI 16K10693)
- the Research on Development of New Medical Devices from Japan Agency for Medical Research and development (AMED) (16hk0102025h0002)
This publication has 15 references indexed in Scilit:
- [Outline of JRS COPD guideline Ed. 4].2016
- Smoking is a perioperative risk factor and prognostic factor for lung cancer surgeryGeneral Thoracic and Cardiovascular Surgery, 2014
- The Impact of Coexisting COPD on Survival of Patients With Early-Stage Non-small Cell Lung Cancer Undergoing Surgical ResectionChest, 2014
- High-intensity training and cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease and non-small-cell lung cancer undergoing lobectomyEuropean Journal of Cardio-Thoracic Surgery, 2013
- Preoperative pulmonary rehabilitation in patients with lung cancer and chronic obstructive pulmonary diseaseEuropean Journal of Cardio-Thoracic Surgery, 2012
- Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnnals of Internal Medicine, 2011
- Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trialEuropean Journal of Cardio-Thoracic Surgery, 2011
- Postoperative exacerbation of chronic obstructive pulmonary disease. Does it exist?☆European Journal of Cardio-Thoracic Surgery, 2008
- Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2007
- Role of Muscarinic Receptor Subtypes in the Constriction of Peripheral Airways: Studies on Receptor-Deficient MiceMolecular Pharmacology, 2003